Target intelligence / Profile preview

Claudin tight junction protein (Claudin)

Target
Claudin
Molecular classification
Tight junction structural protein, Tetraspan transmembrane protein, Cell adhesion molecule (specialized for paracellular barrier function), Other (specifically, not a receptor, enzyme, or transporter in the classical sense)
01

Overview

Claudins are a large family of tetraspan transmembrane proteins that constitute the principal structural components of tight junctions in epithelial and endothelial cells[1][2][6]. They form networks at cell-cell contacts that regulate paracellular transport—the movement of ions, water, and small molecules between adjacent cells—thereby establishing selective barriers critical for tissue homeostasis[1][2]. Each member has four transmembrane domains with two extracellular loops; these loops mediate both homophilic interactions with other claudins on neighboring cells (“trans” interactions) and lateral associations within the same membrane (“cis” interactions), determining both charge selectivity and overall permeability properties[6]. There are over 20 known mammalian claudin isoforms with distinct tissue distributions; their differential expression patterns underlie specialized functions across organs such as kidney tubules, lung alveoli, liver bile ducts, brain endothelium (blood-brain barrier), among others[7]. Alterations in expression levels or mutations affecting specific claudins have been implicated in various diseases including carcinomas—where they may serve both functional roles in metastasis/invasion pathways as well as diagnostic/prognostic biomarkers—and inflammatory disorders where compromised barrier function leads to pathological leakage across epithelia/endothelia[8]. While not classical drug targets like receptors or enzymes due to their structural role at intercellular contacts rather than signaling per se,[9] certain disease-associated isoforms have become targets for antibody-based therapeutics currently under clinical development. In summary: The “Epithelial tight junction protein Claudin” refers collectively to members of the *claudin* family—key determinants of intercellular sealing within tissues—which play essential roles in health by maintaining compartmentalization but also contribute pathologically when dysregulated.

Other names
Tight junction protein claudinClaudin family proteinTJ protein claudinZonula occludens component (context-dependent)Tetraspan membrane protein (context-dependent)
02

Mechanism of action

Experimental drugs/antibodies may act by binding to extracellular loops of specific claudins to disrupt tumor cell adhesion or modulate tight junction integrity; this can lead to increased immune recognition or altered tissue permeability.

03

Biological functions

Formation and maintenance of tight junctions in epithelial and endothelial cellsRegulation of paracellular permeability and selective barrier functionMaintenance of cell polarityControl of ion and solute passage between cells
04

Disease associations

Cancer (altered expression linked to tumorigenesis)Inflammation (barrier dysfunction can contribute to inflammatory diseases)Infection (pathogen entry via disrupted barriers)
05

Safety considerations

Targeting claudins risks disrupting normal epithelial/endothelial barriers, potentially leading to increased tissue permeability, loss of organ-specific barriers such as the blood-brain barrier or gut epithelium integrity, and associated adverse effects like edema or infection susceptibility.
06

Interacting drugs

There are currently no widely approved drugs that directly target claudins as a class. However, some experimental agents and antibodies targeting specific claudins are under investigation for cancer therapy or modulation of barrier function. For example, anti-Claudin 18.2 monoclonal antibodies are being developed for gastric cancer.
07

Biomarkers

Specific claudin isoforms serve as biomarkers in certain cancers—e.g., Claudin 18.2 is used as a biomarker for patient selection in gastric cancer therapies.

Beyond the preview

Go deeper on Claudin tight junction protein (Claudin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claudin tight junction protein (Claudin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call